Resnick / Klein Prostate Cancer Screening

Erscheinungsjahr 2001
ISBN: 978-1-59259-099-5
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 318 Seiten

Reihe: Current Clinical Urology

More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Resnick, Martin I.

Klein, Eric A.

Inhaltsverzeichnis

1 Epidemiology of Prostate Cancer.- 2 Natural History of Prostate Cancer.- 3 Mathematical Issues: PSA Testing.- 4 Evidence of Benefit of Screening in Other Cancers.- 5 The Role of Prostate Specific Antigen and Its Variants in Prostate Cancer Screening.- 6 The Digital Rectal Examination in Prostate Cancer Screening.- 7 Philosophical Reflections on PSA Screening: What Should We Now Think and Do?.- 8 Imaging in Prostate Cancer Screening.- 9 Risk Factors for Prostate Cancer.- 10 Transrectal Ultrasound and Artificial Neural Networks in the Diagnosis of Prostate Cancer.- 11 Evidence of the Effectiveness of Prostate Cancer Screening.- 12 Prostate Cancer Screening: A Note of Caution.- 13 Quality of Life and Health Behavior in Prostate Cancer Screening Populations.- 14 Prostate Cancer Screening Recommendations from Organized Medicine.- 15 Informed Consent and Prostate Specific Antigen Screening: What Patients Ought to Know.- 16 Experience of Prostate Cancer Awareness Week.- 17 The Laval University Screening Trial Results.- 18 Cancer of the Prostate Risk Index Test and Software (CAPRI) [CAPRI Software on Attached CD ROM].- 19 The European Randomized Study of Screening for Prostate Cancer (ERSPC).